Intra-arterial chemotherapy combined with intravesical chemotherapy compared with intravesical BCG immunotherapy retrospectively in high-risk non-muscle-invasive bladder cancer after transurethral resection of the bladder tumor.
Bin HuangGaowei HuangWenji LiLingwu ChenXiaopeng MaoJunxing ChenPublished in: Journal of cancer research and clinical oncology (2020)
IAC combined with IVC used in high-risk NMIBC could reduce the recurrence and progression as effective as BCG instillation with lower adverse events.